Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.8M Sell
295,000
-49,000
-14% -$15.5M 0.44% 51
2026
Q1
$86.2M Sell
344,000
-43,000
-11% -$9.55M 0.52% 43
2025
Q4
$62.7M Buy
387,000
+5,000
+1% +$868K 0.4% 51
2025
Q3
$57.6M Hold
382,000
0.44% 53
2025
Q2
$49.1M Buy
382,000
+55,000
+17% +$5.35M 0.48% 50
2025
Q1
$23.6M Buy
+327,000
New +$34.8M 0.24% 56
2024
Q4
Sell
-7,000
Closed -$696K 209
2024
Q3
$696K Buy
+7,000
New +$580K 0.01% 103
2022
Q2
Sell
-1,407,000
Closed -$19.7M 191
2022
Q1
$19.7M Hold
1,407,000
0.21% 82
2021
Q4
$35.1M Buy
1,407,000
+130,000
+10% +$3.25M 0.38% 70
2021
Q3
$30.8M Sell
1,277,000
-760
-0.1% -$20.2K 0.35% 83
2021
Q2
$34.9M Sell
1,277,760
-339,240
-21% -$8.11M 0.4% 80
2021
Q1
$32.3M Buy
1,617,000
+417,000
+35% +$8.42M 0.37% 85
2020
Q4
$20.9M Buy
+1,200,000
New +$22.1M 0.28% 85

Other funds holding VRT

Clal Insurance's VRT Position: Q2 2026 in Review

Clal Insurance reduced its Vertiv (VRT) stake by 14% in Q2 2026, selling an estimated $15.5M and leaving 295,000 shares worth $98.8M. The position accounts for 0.44% of the portfolio, ranked #51.

Clal Insurance first reported a position in VRT in Q4 2020 and has held it in 13 quarters since. 2,045 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • Clal Insurance held 295,000 shares of Vertiv worth $98.8M as of Q2 2026.
  • Clal Insurance sold 49,000 Vertiv shares in Q2 2026, an estimated $15.5M.
  • Vertiv made up 0.44% of Clal Insurance's portfolio in Q2 2026, its #51 holding.
  • Clal Insurance first reported a position in Vertiv in Q4 2020 and has held it in 13 quarters since.
  • 2,045 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.